Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?

被引：0
|
作者：
Kim, Jong S. [1 ]
机构：
[1] Univ Ulsan, Dept Neurol, Asan Med Ctr, Coll Med, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea
来源：
JOURNAL OF STROKE | 2019年 / 21卷 / 03期
关键词：
D O I：
10.5853/jos.2019.02474
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [21] The Trends in Utilizing Nonvitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Real-Life Experience
    Avci, Burcak Kilickiran
    Vatan, Bulent
    Tok, Ozge Ozden
    Aidarova, Tamara
    Sahinkus, Salih
    Uygun, Turgut
    Gunduz, Huseyin
    Karakaya, Osman
    Yuksel, Husniye
    Ongen, Zeki
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (08) : 785 - 791
  • [22] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
    Sohil Elfar
    Somaya Abdulbaset Mahmoud
    Samar Hamdi
    Aya Ahmed Emad
    Mohamed Abd-ElGawad
    Nouran A. Taha
    BMC Cardiovascular Disorders, 24
  • [23] Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
    Morimoto, Yoshinari
    Yokoe, Chizuko
    Mai, Yuko
    Sugihara, Megumi
    Futatsuki, Toshiko
    JOURNAL OF DENTAL SCIENCES, 2016, 11 (01) : 59 - 64
  • [24] Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist oral anticoagulant
    Mitrovic, Darko
    Plomp, Marlies
    Folkeringa, Richard
    Veeger, Nic
    Feenstra, Talitha
    van Roon, Eric
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1461 - 1466
  • [25] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
    Elfar, Sohil
    Mahmoud, Somaya Abdulbaset
    Hamdi, Samar
    Emad, Aya Ahmed
    Abd-ElGawad, Mohamed
    Taha, Nouran A.
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01)
  • [26] Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure
    Andreu-Cayuelas, Jose M.
    Pastor-Perez, Francisco J.
    Puche, Carmen M.
    Mateo-Martinez, Alicia
    Garcia-Alberola, Arcadio
    Flores-Blanco, Pedro J.
    Valdes, Mariano
    Lip, Gregory Y. H.
    Roldan, Vanessa
    Manzano-Fernandez, Sergio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (02): : 134 - 140
  • [27] What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?
    Shahid, Farhan
    Shantsila, Eduard
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0I) : 18 - 24
  • [28] Editorial Commentary: Optimization of dose selection for nonvitamin K antagonist oral anticoagulants
    Tisdale, James E.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (08) : 573 - 574
  • [29] Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants
    Sarah, Lessire
    Anne-Sophie, Dincq
    Jonathan, Douxfils
    Berangere, Devalet
    Jean-Baptiste, Nicolas
    Anne, Spinewine
    Anne-Sophie, Larock
    Jean-Michel, Dogne
    Maximilien, Gourdin
    Francois, Mullier
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] Non-vitamin K antagonist oral anticoagulant (NOAC) - what was new in 2017?
    Szymanski, Filip M.
    KARDIOLOGIA POLSKA, 2017, 75 : 65 - 70
12345